Please explain how $280k quarterly patient revenues is a lot? This is very very little and for the amount of money being burnt, this is dreadful. Now before the AGH stalwarts start flaming me, let's have a look at what tangible assets that AGH actually have. They have 1500 patients who have been prescribed their drugs (and possibly less than half are still on their drugs). They have a cultivation license on a greenfield site and they are simply selling another company's drugs, rebadged. This is something a competing company could replicate in weeks/ months. These are not the hallmarks of a $220m company.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
Please explain how $280k quarterly patient revenues is a lot?...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
Add AGH (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.15M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 508 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 33310 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 508 | 0.029 |
1 | 20000 | 0.026 |
5 | 631560 | 0.025 |
4 | 351206 | 0.024 |
2 | 318945 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 33310 | 1 |
0.030 | 671311 | 5 |
0.031 | 688000 | 4 |
0.032 | 255661 | 2 |
0.033 | 274000 | 3 |
Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
Featured News
AGH (ASX) Chart |
Day chart unavailable